Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Oncologists raise access concerns about new mobile technology

Article based on interviews.

Key clinical point: Oncologists are raising concerns about care access after the launch of a new company that links patients to cancer care options and clinical trials through a platform known as Driver.

Major finding: Using the technology to link patients with care and clinical trials can help speed treatment and accelerate drug development, oncologists said, but they also expressed concern over the cost of using the service and the limited number of rural hospitals in Driver's network.

Study details: Patients give Driver their required consent to acquire medical records and tumor samples, and the company uses the information to recommend treatment options and clinical trials. A separate app enables oncologists who belong to Driver’s partner hospitals to manage their institution’s clinical trial information and filter it based on patients’ medical history to determine their eligibility for treatments.

Disclosures: Will Polkinghorn, MD, Driver cofounder and CEO, was interviewed for this article.

Read the article.

Citation:

Article based on interviews.